Bank of Nova Scotia Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,104
| Closed | -$201K | – | 134 |
|
|
2024
Q1 | $201K | Buy |
+1,104
| New | +$190K | 0.02% | 137 |
|
|
2022
Q2 | – | Sell |
-1,430
| Closed | -$232K | – | 132 |
|
|
2022
Q1 | $232K | Buy |
+1,430
| New | +$208K | 0.02% | 132 |
|
|
2021
Q3 | – | Sell |
-3,409
| Closed | -$384K | – | 141 |
|
|
2021
Q2 | $384K | Buy |
3,409
+3
| +0.1% | +$338 | 0.03% | 105 |
|
|
2021
Q1 | $369K | Buy |
3,406
+28
| +0.8% | +$3K | 0.04% | 107 |
|
|
2020
Q4 | $362K | Sell |
3,378
-24
| -0.7% | -$2.31K | 0.04% | 103 |
|
|
2020
Q3 | $298K | Buy |
3,402
+2
| +0.1% | +$188 | 0.04% | 94 |
|
|
2020
Q2 | $334K | Sell |
3,400
-150
| -4% | -$13.2K | 0.05% | 81 |
|
|
2020
Q1 | $270K | Hold |
3,550
| – | – | 0.04% | 89 |
|
|
2019
Q4 | $314K | Sell |
3,550
-3
| -0.1% | -$249 | 0.04% | 90 |
|
|
2019
Q3 | $269K | Sell |
3,553
-5
| -0.1% | -$343 | 0.03% | 93 |
|
|
2019
Q2 | $259K | Sell |
3,558
-342
| -9% | -$26.9K | 0.03% | 103 |
|
|
2019
Q1 | $314K | Hold |
3,900
| – | – | 0.04% | 90 |
|
|
2018
Q4 | $360K | Sell |
3,900
-809
| -17% | -$71.1K | 0.05% | 83 |
|
|
2018
Q3 | $445K | Hold |
4,709
| – | – | 0.05% | 87 |
|
|
2018
Q2 | $436K | Hold |
4,709
| – | – | 0.05% | 84 |
|
|
2018
Q1 | $446K | Hold |
4,709
| – | – | 0.05% | 81 |
|
|
2017
Q4 | $455K | Sell |
4,709
-3,645
| -44% | -$344K | 0.05% | 84 |
|
|
2017
Q3 | $743K | Buy |
8,354
+30
| +0.4% | +$2.28K | 0.08% | 80 |
|
|
2017
Q2 | $604K | Sell |
8,324
-376
| -4% | -$25.3K | 0.07% | 81 |
|
|
2017
Q1 | $567K | Buy |
8,700
+184
| +2% | +$11.6K | 0.06% | 78 |
|
|
2016
Q4 | $533K | Sell |
8,516
-299
| -3% | -$18.3K | 0.06% | 78 |
|
|
2016
Q3 | $556K | Sell |
8,815
-3,543
| -29% | -$229K | 0.07% | 79 |
|
|
2016
Q2 | $765K | Sell |
12,358
-6,700
| -35% | -$408K | 0.1% | 72 |
|
|
2016
Q1 | $1.09M | Sell |
19,058
-10,776
| -36% | -$601K | 0.15% | 63 |
|
|
2015
Q4 | $1.77M | Sell |
29,834
-18,473
| -38% | -$1.06M | 0.27% | 58 |
|
|
2015
Q3 | $2.63M | Sell |
48,307
-63,073
| -57% | -$4.11M | 0.37% | 56 |
|
|
2015
Q2 | $7.6M | Sell |
111,380
-20,654
| -16% | -$1.35M | 0.97% | 25 |
|
|
2015
Q1 | $7.73M | Sell |
132,034
-19,444
| -13% | -$1.17M | 1% | 25 |
|
|
2014
Q4 | $9.91M | Sell |
151,478
-3,112
| -2% | -$196K | 1.2% | 23 |
|
|
2014
Q3 | $8.93M | Buy |
154,590
+4,119
| +3% | +$229K | 1.04% | 23 |
|
|
2014
Q2 | $8.56M | Sell |
150,471
-3,768
| -2% | -$198K | 0.92% | 28 |
|
|
2014
Q1 | $7.93M | Sell |
154,239
-624
| -0.4% | -$31.5K | 1.06% | 27 |
|
|
2013
Q4 | $8.18M | Buy |
154,863
+19,130
| +14% | +$940K | 1.11% | 24 |
|
|
2013
Q3 | $6.07M | Buy |
135,733
+1,728
| +1% | +$76.6K | 0.87% | 27 |
|
|
2013
Q2 | $5.8M | Buy |
+134,005
| New | +$5.86M | 0.85% | 30 |
|
Other funds holding ABBV
Bank of Nova Scotia Trust's ABBV Position: Q2 2024 in Review
Bank of Nova Scotia Trust sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 1,104 shares — an estimated $201K sold.
Bank of Nova Scotia Trust first reported a position in ABBV in Q2 2013 and held it in 35 quarters. The position peaked at $9.91M in Q4 2014. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.
- Bank of Nova Scotia Trust reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
- Bank of Nova Scotia Trust sold 1,104 AbbVie shares in Q2 2024, an estimated $201K.
- Bank of Nova Scotia Trust first reported a position in AbbVie in Q2 2013 and held it in 35 quarters.
- Bank of Nova Scotia Trust's AbbVie position peaked at $9.91M in Q4 2014.
- 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.
Based on Bank of Nova Scotia Trust's 13F filing for Q2 2024, filed 14 Aug 2024.